Development of new drugs based on the metabolic activation by intestinal bacteria.
Development of new drugs based on the metabolic activation by intestinal bacteria.
批准号:
09557178
负责人:
HATTORI Masao
金额:
$8.32万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999
中文摘要
1.芍药苷衍生物的合成及其抗惊厥活性通过芍药苷与人肠道细菌Lactobacillus brevis在巯基化合物存在下的孵育反应,合成了17种不同的芍药苷衍生物,并对其抗惊厥活性进行了研究,其中8-(正己硫基)-、8-环戊硫基-、8-(对甲苯硫基)-和8-苯甲酰基硫基芍药苷具有较强的抗惊厥活性。最后一个化合物经柱层析分离后,7S-衍生物显示出最强的抗惊厥活性,而7 R-衍生物显示出肌肉松弛作用.大肠杆菌Rb_1的代谢产物(20 S)-原人参二醇20-O-葡萄糖苷(20 S-Protopanaxadiol 20-O-glucoside)对小鼠肿瘤转移有明显的抑制作用。其抗肿瘤转移作用机制研究表明,该代谢产物通过调节细胞周期蛋白D、p27 kip和c-myc等凋亡相关蛋白,诱导肿瘤细胞凋亡.肠道细菌介导的新反应的发展。将大黄酸转化为大黄蒽酮。去甲基化c.脱羟基在上述项目的研究过程中,我们分离出三种细菌菌株拟杆菌属,消化链霉菌属,和真杆菌属,从人类粪便中提取,它催化了新的反应a-c。
英文摘要
1. Synthesis of paeonimetabolin derivatives and their anti-convulsant activityBy incubation of paeoniflorin from peony roots with a human intestinal bacterium Lactobacillus brevis in the presence of mercapto compounds, 17 different kinds of paeonimetabolin derivatives were prepared and examined their anti-convulsant activity ; 8-(n-hexylthio)-, 8-cyclopentylthio-, 8-(p-tolylthio)-, and 8-benzoylthiopaeonimetabolin showed potent activity. After separation of the last compound by column chromatography, 7S-derivative showed the most potent anti-convulsant activity, but 7R-derivative showed the muscle relaxation effect.2. Effects of a metabolite of ginsenoside by intestinal bacteria on metastasis and apoptosis of tumor cellsA metabolite (20S)-protopanaxadiol 20-O-glucoside of ginsenoside Rb1 showed potent anti-metastatic action in mice. As to the mechanism of the anti-metastatic action, it was demonstrated that this metabolite induced apoptosis of the tumor cells by modulating apoptosis related proteins such as cyclin D, p27 kip and c-myc etc.3. Development of new reactions mediated by intestinal bacteria.a. Conversion of rhein to rhein anthroneb. Demethylationc. DehydroxylationDuring the investigation under the above project, we islated three bacterial strains Bacteroides sp., Peptostreptococcus sp., and Eubacterium sp., from human feces, which catalyzed the new reactions a-c.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kida H. et al.: "Metabolism and Pharmacokinetics of Orally Administered Saikosaponin b1 in Conventional, Germ-Free and Eubacterium sp. A-44 Infected Gnotobiote Rats"Biol. Pharm. Bull.. 21. 588-593 (1998)
Kida H. 等人:“传统、无菌和真杆菌属 A-44 感染的知生物大鼠中口服柴胡皂苷 b1 的代谢和药代动力学”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Abdel-Hafez A. A. et al.: "Anticonvulsant activity of paeonimetabolin-I adducts obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis."Biol. Pharm. Bull.. 22. 491-497 (1999)
Abdel-Hafez A. A. 等人:“通过将芍药苷和硫醇化合物与短乳杆菌一起孵育,获得芍药代谢素-I 加合物的抗惊厥活性。”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawata Y. et al.: "Conversion of aconitine to lipoaconitine by human intestinal bacteria and their antinoceptive effects in mice."J. Trad. Med.. 16. 15-23 (1999)
Kawata Y. 等人:“人类肠道细菌将乌头碱转化为脂乌头碱及其对小鼠的镇痛作用。”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kida H. et al.: "Isolation and identification of human intestinal bacteria capable of hydrolyzing saikosaponins"J. Trad. Med.. 14. 34-40 (1997)
Kida H.等人:“能够水解柴胡皂苷的人体肠道细菌的分离和鉴定”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasegawa H. et al.: "Synthesis of a biologically active fluorescent derivative of GM1, a main ginseng saponin metabolite formed by intestinal bacteria"Biol. Pharm. Bull.. 21. 513-516 (1998)
Hasekawa H.等人:“GM1的生物活性荧光衍生物的合成,GM1是肠道细菌形成的主要人参皂苷代谢物”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 36 条
海外基金